MedPath

RIVA-CYCLOBENZAPRINE

RIVA-CYCLOBENZAPRINE

Approved
DIN Number

02242079

Drug Class

Human

Market Date

May 23, 2000

Company
HC

laboratoire riva inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02242079
AIG Number0112363001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M03BX08 CYCLOBENZAPRINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification12:20.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

CYCLOBENZAPRINE HYDROCHLORIDEActive
Strength: 10 MG
Monograph: CYCLOBENZAPRINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.